Resercher training in Rio: Using CRISPR to illuminate new solutions for two old, ‘invisible’ diseases
July, 2018; and as the cool of evening descends over Rio de Janeiro, 22 young researchers from South America and the UK gather, excited and a little nervous, to meet each other and their tutors for the next 5 days. The teaching team of 9 international experts are here to provide training in use of CRISPR-Cas9 technology in trypanosomes (Tryps), the parasites that cause the neglected tropical diseases (NTDs) Chagas disease (American trypanosomiasis) and leishmaniasis. The students’ excitement is justified; their new skills will transform their professional lives, and may also be life-changing for many of the ~0.5 billion people worldwide at risk from these infections.1-4
It is a hot May afternoon in Lucknow; members of the Global Network for Neglected Tropical Diseases (NTDs) take a break from the first ‘Hub leader’s meeting’, escaping the heat and throat-catching pollution to the tranquil gardens of the Bara Imambara (‘Court of the Imam’) and its famous maze, Bhul Bhulaiya. The Network’s aim is to find targets for new drugs to treat two NTDs, Chagas disease and leishmaniasis. The venue today seems apt; not only are these infections a vast biological puzzle, but also, behind the scenes, the Network’s 14 institutions are currently negotiating a maze of bureaucratic red tape to ratify the necessary legal requirements which will allow them to commence their international programme of collaborative work.
A Burns night inauguration for the team to tame the ‘tim’rous beasties’ of Chagas disease and leishmaniasis